Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Infect Dis ; 223(9): 1564-1575, 2021 05 20.
Article in English | MEDLINE | ID: mdl-32860509

ABSTRACT

BACKGROUND: Little is known about characteristics of seasonal human coronaviruses (HCoVs) (NL63, 229E, OC43, and HKU1) after allogeneic stem cell transplantation (allo-HSCT). METHODS: This was a collaborative Spanish and European bone marrow transplantation retrospective multicenter study, which included allo-HSCT recipients (adults and children) with upper respiratory tract disease (URTD) and/or lower respiratory tract disease (LRTD) caused by seasonal HCoV diagnosed through multiplex polymerase chain reaction assays from January 2012 to January 2019. RESULTS: We included 402 allo-HSCT recipients who developed 449 HCoV URTD/LRTD episodes. Median age of recipients was 46 years (range, 0.3-73.8 years). HCoV episodes were diagnosed at a median of 222 days after transplantation. The most common HCoV subtype was OC43 (n = 170 [38%]). LRTD involvement occurred in 121 episodes (27%). HCoV infection frequently required hospitalization (18%), oxygen administration (13%), and intensive care unit (ICU) admission (3%). Three-month overall mortality after HCoV detection was 7% in the whole cohort and 16% in those with LRTD. We identified 3 conditions associated with higher mortality in recipients with LRTD: absolute lymphocyte count <0.1 × 109/mL, corticosteroid use, and ICU admission (hazard ratios: 10.8, 4.68, and 8.22, respectively; P < .01). CONCLUSIONS: Seasonal HCoV after allo-HSCT may involve LRTD in many instances, leading to a significant morbidity.


Subject(s)
Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Hematopoietic Stem Cell Transplantation , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/etiology , Adolescent , Adult , Aged , Betacoronavirus , Child , Child, Preschool , Coronavirus 229E, Human , Coronavirus Infections/mortality , Coronavirus NL63, Human , Coronavirus OC43, Human , Female , Hospitalization , Humans , Infant , Male , Middle Aged , Respiratory Tract Infections/mortality , Retrospective Studies , Risk Factors , Seasons
2.
Actas Urol Esp ; 33(7): 826-9, 2009.
Article in Spanish | MEDLINE | ID: mdl-19757671

ABSTRACT

We describe a case of primary penis lymphoma in a 71 yr old man. We review the bibliography and we emphasize the peculiarity and different sorts of clinical presentation. The initial symptoms were insidious. Physical examination and ultrasound findings made it indistinguishable from other tumors. A MRI confirmed the presence of a tumoral process with a homogeneous density in the distal part of the penis whose biopsy with immune histological processing confirmed us the diagnosis of primary penis lymphoma. The combined treatment with chemotherapy and radiotherapy allowed preserving the sexual organ and being without disease at 48 month of follow up.


Subject(s)
Lymphoma, Large B-Cell, Diffuse , Penile Neoplasms , Aged , Humans , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/surgery , Male , Penile Neoplasms/diagnosis , Penile Neoplasms/surgery
3.
Med Clin (Barc) ; 146(1): 16-9, 2016 Jan 01.
Article in Spanish | MEDLINE | ID: mdl-26343154

ABSTRACT

BACKGROUND: Bacterial infection remains a frequent complication in patients receiving a hematopoietic stem cell transplantation (HSCT). However, the impact of the antibacterial prophylaxis mortality in these patients is controversial. PATIENTS AND METHODS: Retrospective comparison of 2 consecutive groups of patients undergoing HSCT receiving (n=132) or not (n=107) antibacterial prophylaxis with levofloxacin. RESULTS: 41% of patients receiving prophylaxis with levofloxacin had microbiologically documented infection (MDI) with bacteremia, compared with 40% of those not receiving levofloxacin. The frequency of gram-negative bacteremia was 11 and 38%, the resistance to levofloxacin was 39 and 14%, and the mortality was 8 and 7%, respectively. CONCLUSIONS: In our experience, the use of levofloxacin as prophylaxis in HSCT was associated with a lower frequency of gram-negative bacteremia but was not associated with a decreased rate of MDI and did not influence their outcome. In contrast, there was an increase in quinolone resistance in patients treated with levofloxacin.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Bacteremia/prevention & control , Gram-Negative Bacterial Infections/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Levofloxacin/therapeutic use , Adolescent , Adult , Aged , Bacteremia/etiology , Female , Gram-Negative Bacterial Infections/etiology , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL